In type-one diabetes (T1D), pumps delivering continuous insulin infusions alongside continuous blood glucose monitoring are increasingly becoming standard management. The next logical step is to link these devices intelligently, so that the patient does not have to check their glucose levels at all: known as a ‘closed-loop’ system, it is effectively an electronic ‘artificial pancreas’. But does this advanced technology actually improve diabetic control?. To read the full article, log in using your NHS OpenAthens details.